| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K85133207 |
| PharmacoGx | BRD-K85133207 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TOP3A | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | TAGLN2 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | SENP7 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | EVI2A | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | RAB3IP | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | RTN1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | FXYD6 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | CT45A6 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | SLC15A3 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | LYVE1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
